Authors
Latest:
Congress Leaves Town with Major Drug-Related Bills on HoldPandemic preparedness and curbing PBMs among the pending legislation that will have to wait until after summer recess.
Latest:
What’s Next for Biopharma Under the Inflation Reduction ActAs we approach the one-year anniversary of the IRA being signed into law, questions remain about how the new law will reverberate changes across the biopharma industry.
Latest:
Strategic Trends in Pharmaceutical Manufacturing for Industry LeadersThis link in the pharma supply chain is undergoing a major transformation propelled by technological advancements, regulatory changes, and evolving market dynamics, requiring industry leaders to adopt innovative strategies in order to remain competitive.
Latest:
Positioning the Patient in Drug TrialsThe clinical research industry must integrate feedback from patients and sites to eliminate unnecessary burden and accelerate enrollment in clinical trials
Latest:
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Latest:
Developing Your Roadmap to Pharma 4.0Questions to ask before transitioning into new technologies. By Yvonne Duckworth and Cory Perelman.
Latest:
Exploring the Digital Therapeutics LandscapeObservations from recent digital health events and a glimpse of what’s ahead—from Milan to Boca Raton
Latest:
What is a Digital Hub in 2023?Deciphering the different "technology-first” and “technology-enabled” patient support programs.
Latest:
Seeing the Value of Scientific ContentLeveraging the value healthcare professionals place on scientific content
Latest:
Strategizing High-Wire, Multi-Indication LaunchesProperly supporting market access for a newly launched product with a single indication is challenging. Doing so for multiple indications, or supporting subsequent indications, can have a compounding effect on the degree of difficulty for getting everything right.
Latest:
Chatbot Potential in Clinical ResearchHow AI-powered support automation can solve the data problem in clinical trial management
Latest:
Is Trust the Secret Ingredient for Digital Product Success?To rebuild trust, companies should utilize a customer-centric approach, focusing on transparent and neutral content incorporating medical expertise and regularly seeking HCP feedback.
Latest:
Global Logistics: A Cold Chain BlueprintThe growing pipeline of cold chain products holds tremendous promise for patients, but can result in failed shipments if not properly planned for
Latest:
Why Multimodal Data is Growing in PharmaMaking connections between different datasets is essential to developing impactful medicines and driving more personalized patient care.
Latest:
Flipping the Switch on DSCSA InteroperabilityFrom November 2023, the Drug Supply Chain Security Act requires healthcare manufacturers, distributors, providers, and dispensers to exchange the serialized item-level product information that has been collected, standardized, and digitized. Hitting this deadline hinges on intensive collaboration between manufacturers and their supply chain partners that must begin now
Latest:
No More Excuses: It’s Time to Invest in the PharmacyOrganizations can go a long way toward ushering in the pharmacy of the future and enabling safer, more efficient care by implementing an intelligent infrastructure of technology.
Latest:
Breaking Point: How 2025 Will Reshape Patient Support ServicesFrom matrix programs to anti-abandonment strategies, predictions for a new era.
Latest:
Rethinking NCPs in support mixNon-commercial pharmacies can be secret weapons for intake and adherence
Latest:
The Opportunity for SustainabilityPharma’s prime chance to reduce carbon emissions from supply chain
Latest:
Achieving Efficient, Optimized, and Compliant Production at ScaleInnovation in pharma manufacturing as paradigms shift and biotech and personalized therapies move through clinical trials at pace
Latest:
Patient Data: Solving Ownership QuestionHow privacy and technology literacy can coexist behind a blockchain-based approach to patient data analytics and control
Latest:
How State Privacy Laws Are Shaping DTC and HCP Marketing StrategiesWhy they are a game changer, and ways to a adapt to a new era of state privacy regulations.
Latest:
Creating a Future-Ready Chemicals and Materials Lab Vital for GrowthTeams need to keep close track of ingredients, processing parameters, and material performance so that they can use their R&D data to decide exactly which materials to make next.
Latest:
FDA Gives Alzheimer’s Drug Leqembi Full Approval. That Means Medicare Coverage But...Medicare-eligible patients need to be enrolled in registry to get Medicare coverage for the anti-beta amyloid drug that is priced to cost $26,500 a year.
Latest:
Shipping Strategies in Unusual TimesThe steps pharma manufacturers can take to mitigate transportation costs amid Covid’s supply-chain crunch
Latest:
Expert: Digital Transformation is Key Part of Biopharma C-Suite Goals for 2024Stephanie L. Woerner, PhD, director and principal research scientist at the MIT Center for Information Systems Research, discusses the outlook for next year among biopharma firms.
Latest:
Unique Challenges to Market Access for Ophthalmology BiosimilarsCatherine Humphries sheds light on three key market access challenges within the ophthalmology biosimilars space.
Latest:
Closing the Health Literacy and Diversity Gaps in Clinical TrialsNew engagement approaches can help drive treatment gains in underrepresented communities.
